Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
--KKR & Co Said to be Mulling $1 Billion Healthium Medtech Acquisition, Bloomberg Reports
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
--KKR & Co Said to be Mulling $1 Billion Healthium Medtech Acquisition, Bloomberg Reports
Apr 24, 2024 5:40 AM
08:20 AM EDT, 04/24/2024 (MT Newswires) --
Price: 98.25, Change: +0.28, Percent Change: +0.29
Previous page:
Commerzbank on Overnight News
Next page:
US Cellular to Sell Certain Spectrum Licenses to AT&T For $1.02 Billion
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
Commerzbank on Overnight News
Nov 8, 2024
06:13 AM EST, 11/08/2024 (MT Newswires) -- Commerzbank in its European Sunrise note of Friday highlighted: Markets: United States Treasuries stable in Asia after consolidating Federal Reserve gains, e-minis sideways after S&P closes on new high, Asian equities mixed. EURUSD falls back below 1.08 overnight, oil softer. Fed cuts by 25bps, unanimous decision. Chair Jerome Powell says he isn't ruling...
US Cellular to Sell Certain Spectrum Licenses to AT&T For $1.02 Billion
Nov 8, 2024
01:38 PM EST, 11/07/2024 (MT Newswires) -- US Cellular (USM) said Thursday it agreed to sell some of its spectrum licenses to telecommunications giant AT&T ( T ) for about $1.02 billion in cash. The tower operator said the deal is part of its plan to monetize the spectrum that was excluded from its May agreement with T-Mobile US (...
Atmus Filtration Technologies' Q3 Adjusted Earnings, Net Sales Rise; 2024 Guidance Revised
Nov 8, 2024
06:56 AM EST, 11/08/2024 (MT Newswires) -- Atmus Filtration Technologies ( ATMU ) reported Q3 adjusted earnings Friday of $0.61 per share, up from $0.52 a year earlier. Analysts polled by Capital IQ expected $0.52. Net sales for the quarter ended Sept. 30 were $403.7 million, up from $396.2 million a year earlier. Analysts surveyed by Capital IQ expected $403.4...
BRIEF-Allovir And Kalaris Therapeutics Announce Merger To Form Company Focused On Retinal Diseases
Nov 8, 2024
Nov 8 (Reuters) - Allovir Inc ( ALVR ): * ALLOVIR AND KALARIS THERAPEUTICS ANNOUNCE AGREEMENT FOR TRANSFORMATIONAL MERGER TO CREATE COMPANY FOCUSED ON DISEASES OF THE RETINA * ALLOVIR INC ( ALVR ) - TO ACQUIRE 100% OF KALARIS EQUITY INTEREST * ALLOVIR INC ( ALVR ) - STOCKHOLDERS TO OWN 25.05% OF COMBINED COMPANY POST-MERGER * ALLOVIR INC...
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2026 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP